Reports
Reports
Sale
The global spirometer market size was valued at USD 1,161.1 million in 2023, driven by the increasing prevalence of respiratory diseases across the globe. The market size is anticipated to grow at a CAGR of 8.31% during the forecast period of 2024-2032 to achieve a value of USD 2,371.2 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
A spirometer is a handheld tool used to examine lung capacity by measuring the volume of air inhaled and exhaled by the lungs. Spirometers help diagnose breathing issues, be it cough, shortness of breath, or mucus production. Spirometry tests should be avoided in situations such as active tuberculosis, coughing of blood, and pneumothorax, among other complications.
The increasing prevalence of chronic obstructive pulmonary disease is subjected to an increase in the demand for diagnostics and monitoring equipment such as spirometers, fueling the spirometer market growth. Developments are being carried out in spirometer technology to simplify operations and reduce the complications involved in pulmonary function testing procedures. New designs with improved features are expected to increase the demand for spirometers in the forecast period.
Innovating packaging methods are being adopted by companies to avoid bacterial or other infections between users, making it safer to use by patients in the long term. Spirometers are often recommended by doctors to patients’ post-surgery to monitor lung performance and general breathing conditions. The rising use of spirometers in hospital settings and the homes of people with breathing issues is another key trend influencing the market.
Rising Prevalence of Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. Nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries. COPD is the seventh leading cause of poor health worldwide (measured by disability-adjusted life years). Tobacco smoking accounts for over 70% of COPD cases in high-income countries. In low- and middle-income countries, tobacco smoking accounts for 30–40% of COPD cases, and household air pollution is a major risk factor. The spirometer market demand may experience significant growth owing to the rising prevalence of COPD across the low- and middle-income countries.
Increasing Product Launches in the Market
In August 2023, A breakthrough in COPD assessment was launched nationwide for the regulated AI technology for COPD, which uses the N-Tidal device. The technology combines N-Tidal’s high-resolution CO2 sensor data with an artificial intelligence platform that measures changes in lung function that might point toward a diagnosis of COPD. The ground-breaking medical tool can indicate a patient’s risk of COPD within minutes.
The nationwide launch of regulated AI technology for COPD, utilizing the N-Tidal device, is poised to significantly impact the global spirometer market by providing a rapid and advanced solution for assessing COPD risk. The ability to quickly indicate COPD risk may drive increased demand for such innovative spirometry technologies worldwide, contributing to the spirometer market share.
Rise in FDA Approvals to Aid the Market
In September 2023, Alveofit (Roundworks Technologies) received approval from the US Food and Drug Administration (FDA) for its portable digital spirometer, alveoair. The company aims to start the distribution of the product in the US followed by this approval. It also claimed that along with the FDA approval, an alliance with AstraZeneca will expand its international business, particularly in the US and emerging economies. The CDSCO-certified alveoair is allegedly India’s first US FDA-cleared spirometer and is adopted by more than 400 healthcare facilities across India. In India, alveofit partnered with various companies, including NASSCOM COE, Forge Innovation & Ventures, PATH, DST, and the India Sweden Innovation Centre.
The global spirometer market growth is anticipated to be driven by this FDA approval for alveoair spirometer, coupled with an alliance with AstraZeneca. The approval will enable product distribution in the US, fostering international growth, especially in the US and emerging economies. The product's integration into alveofit's ecosystem, providing real-time insights and predictive analytics, enhances respiratory care and positions the company for expanded market influence.
Increase in Research Activities
In 2023, NuvoAir presented a research study entitled ‘Quality and adherence of home spirometry in a remote respiratory physiologist-led assessment’ at the Association for Respiratory Technology and Physiology (ARTP) Annual Conference in Brighton. The poster outlined results from a retrospective analysis of NuvoAir’s 12-week Asthma Assessment Service in the UK and its impacts on the accurate diagnosis, management, and treatment of respiratory disease.
NuvoAir's research suggests that combining home assessment programs with remote physiologist support improves respiratory disease diagnosis and treatment. This advancement may boost global spirometer demand, driving growth in the market during the forecast period.
Additionally, In April 2023, Bogdan’s research team harnessed the power of artificial intelligence (AI) by sharing the findings from a study in the research paper entitled ‘Fractional Dynamics Foster Deep Learning of COPD Stage Prediction’. It was emphasized by the company that the device determines a diagnosis with 98.5% accuracy. The device is a wearable patch usually on the arm, embedded with a sensor. The device monitors 12 signal records such as the respiratory inductance plethysmography (RIP), which signals breathing efforts, and the wireless pulse-oximeter, which signals oxygen saturation levels while the doctor completes the normal physiological exam on the patient. In addition to this increased accuracy, this new device makes COPD diagnosis and monitoring easier. This AI-powered spirometer system, offering rapid and accurate COPD diagnosis with its cost-effectiveness, remote monitoring capabilities, and potential for widespread use, is expected to support the global spirometer market growth, challenging traditional models, and expanding accessibility to respiratory care.
Global Initiatives to Provide Significant Impetus
The market is poised to be influenced by global initiatives to curb the prevalence of non-communicable diseases such as the inclusion of COPD in the WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases (NCDs) and the United Nations 2030 Agenda for Sustainable Development. WHO is taking action to extend the diagnosis of and treatment for COPD in several ways. The WHO Package of Essential Noncommunicable Disease Interventions (PEN) was developed to help improve NCD management in primary health care in low-resource settings.
The inclusion of COPD in WHO's global health initiatives, such as the Global Action Plan and Rehabilitation 2030, could drive increased demand for spirometers globally. As WHO focuses on extending diagnosis and treatment, the spirometer market is expected to witness significant growth due to the rising importance of managing chronic respiratory diseases.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product Type
Market Breakup by Technology
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Considering the geographical landscape, North America is leading the market. The market is expected to dominate in the forecast period due to factors such as the increasing number of asthma and COPD cases. Due to the rise in these cases, the region has experienced a significant boost in the usage of spirometers, aiding disease control by doctors in hospitals. The market is further influenced by increasing research studies poised to bring innovation to the market.
For instance, in January 2023, Koneksa, a healthcare technology company developing evidence-based validated digital biomarkers, launched a clinical study comparing the treatment effect between at-home mobile spirometry using digital biomarkers and in-clinic spirometry in patients with moderate asthma on long-acting beta-agonist (LABA) treatment. This study may influence the global spirometer market by shaping preferences toward digital solutions . If proven effective, it may drive increased adoption of digital biomarker-based spirometry, impacting market growth during the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
In January 2023, CAIRE Inc., the leading global manufacturer of oxygen therapy and on-site generation systems acquired Minnesota-based MGC Diagnostics Holdings, Inc. (MGC). This acquisition strengthens CAIRE’s position and focus on diagnostic technologies further expanding its expertise in serving patients throughout the progression of pulmonary disease.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Technology |
|
Breakup by Applications |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Spirometer Market (2017-2032) Overview
3.1 Global Spirometer Market (2017-2032) Historical Value (2017-2023)
3.2 Global Spirometer Market (2017-2032) Forecast Value (2024-2032)
4 Global Spirometer Market (2017-2032) Landscape
4.1 Global Spirometer Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Spirometer Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Application
5 Global Spirometer Market (2017-2032) Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Spirometer Market (2017-2032) Segmentation
6.1 Global Spirometer Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 Devices
6.1.3 Software
6.1.4 Consumables and Accessories
6.2 Global Spirometer Market (2017-2032) by Technology
6.2.1 Market Overview
6.2.2 Volume Measurement
6.2.3 Flow Measurement
6.3 Global Spirometer Market (2017-2032) by Application
6.3.1 Market Overview
6.3.2 Asthma
6.3.3 COPD
6.3.4 Fibrosis
6.3.5 Other Applications
6.4 Global Spirometer Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinical Laboratories
6.4.4 Home Care Settings
6.4.5 Other Applications
6.5 Global Spirometer Market (2017-2032) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
7 North America Spirometer Market (2017-2032)
7.1 North America Spirometer Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Devices
7.1.3 Software
7.1.4 Consumables & Accessories
7.2 North America Spirometer Market (2017-2032) by Technology
7.2.1 Market Overview
7.2.2 Volume Measurement
7.2.3 Flow Measurement
7.3 North Spirometer Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Spirometer Market (2017-2032)
8.1 Europe Spirometer Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Devices
8.1.3 Software
8.1.4 Consumables & Accessories
8.2 Europe Spirometer Market (2017-2032) by Technology
8.2.1 Market Overview
8.2.2 Volume Measurement
8.2.3 Flow Measurement
8.3 Europe Spirometer Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Spirometer Market (2017-2032)
9.1 Asia Pacific Spirometer Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Devices
9.1.3 Software
9.1.4 Consumables & Accessories
9.2 Asia Pacific Spirometer Market (2017-2032) by Technology
9.2.1 Market Overview
9.2.2 Volume Measurement
9.2.3 Flow Measurement
9.3 Asia Pacific Spirometer Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 ASEAN
9.3.6 Others
10 Latin America Spirometer Market (2017-2032)
10.1 Latin America Spirometer Market (2017-2032) by Product Type
10.1.1 Market Overview
10.1.2 Devices
10.1.3 Software
10.1.4 Consumables & Accessories
10.2 Latin America Spirometer Market (2017-2032) by Technology
10.2.1 Market Overview
10.2.2 Volume Measurement
10.2.3 Flow Measurement
10.3 Latin Spirometer Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Spirometer Market (2017-2032)
11.1 Middle East and Africa Spirometer Market (2017-2032) by Product Type
11.1.1 Market Overview
11.1.2 Devices
11.1.3 Software
11.1.4 Consumables & Accessories
11.2 Middle East and Africa Spirometer Market (2017-2032) by Technology
11.2.1 Market Overview
11.2.2 Volume Measurement
11.2.3 Flow Measurement
11.3 Middle East and Africa Spirometer Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
17 Supplier Landscape
17.1 MGC Diagnostic Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Teleflex Incorporated
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 SCHILLER AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Vyaire medical
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Midmark Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Smiths Medical, Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Nspire health Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 COSMED srl
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Hill-Rom, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Vitalograph
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Fukuda Sangyo
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Fysiomed
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Sibelmed
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Jones Medical Instrument Company
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Medriko
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Contec Medical Systems Co. Ltd.
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
18 Global Spirometer Market (2017-2032) Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
The market attained a value of about USD 1,161.1 million in 2023, driven by increasing cases of COPD.
The market is anticipated to grow at a CAGR of 8.31% during the forecast period of 2024-2032 and is likely to reach a market value of USD 2,371.2 million by 2032.
Factors including the increasing prevalence of chronic obstructive pulmonary diseases, rising demand for diagnostics, and monitoring equipment, increasing technological advancements, FDA approvals, research activities, global initiatives by non-government organizations such as the WHO, and strategic collaborations between key players are aiding the market demand.
The increasing product launches by market players including the launch of the N-Tidal device, is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The spirometer products in the market include devices, software, consumables, and accessories.
Spirometers have volume measurement and flow measurement.
Spirometers find wide applications in Asthma, COPD, and fibrosis, among other applications.
End users include hospitals, clinical laboratories, and home care settings, among other applications.
Key players involved in the market are MGC Diagnostic Corporation, Teleflex Incorporated, SCHILLER AG, Vyaire Medical, Midmark Corporation, Smiths Medical, Inc., Nspire Health Inc., COSMED srl, Hill-Rom, Inc., Vitalograph, Fukuda Sangyo, Fysiomed, Sibelmed, Jones Medical Instrument Company, Contec Medical Systems Co. Ltd., and Medriko.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.